Trademark: 87174410
Word
JULIPTA
Status
Dead
Status Code
605
Status Date
Thursday, April 30, 2020
Serial Number
87174410
Mark Type
4000
Filing Date
Friday, September 16, 2016
Published for Opposition
Tuesday, January 31, 2017
Abandoned Date
Wednesday, April 29, 2020

Trademark Owner History
Allergan Sales, LLC - Owner At Publication

Classifications
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; Pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and formulations pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body

Trademark Events
Apr 30, 2020
Abandonment Notice E-Mailed - After Publication
Apr 30, 2020
Abandonment - After Publication
Apr 29, 2020
Teas Express Abandonment Received
Sep 25, 2019
Notice Of Approval Of Extension Request E-Mailed
Sep 24, 2019
Extension 5 Granted
Sep 20, 2019
Extension 5 Filed
Sep 24, 2019
Case Assigned To Intent To Use Paralegal
Sep 20, 2019
Teas Extension Received
Mar 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2019
Extension 4 Granted
Mar 1, 2019
Extension 4 Filed
Mar 1, 2019
Teas Extension Received
Sep 11, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 7, 2018
Extension 3 Granted
Sep 7, 2018
Extension 3 Filed
Sep 7, 2018
Teas Extension Received
Feb 1, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 30, 2018
Extension 2 Granted
Jan 30, 2018
Extension 2 Filed
Jan 30, 2018
Teas Extension Received
Aug 18, 2017
Notice Of Approval Of Extension Request E-Mailed
Aug 16, 2017
Extension 1 Granted
Aug 16, 2017
Extension 1 Filed
Aug 16, 2017
Teas Extension Received
Mar 28, 2017
Noa E-Mailed - Sou Required From Applicant
Mar 4, 2017
Changes/Corrections After Pub Approval Entered
Mar 3, 2017
Assigned To Petition Staff
Feb 16, 2017
Teas Post Publication Amendment Received
Jan 31, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 31, 2017
Published For Opposition
Jan 11, 2017
Notification Of Notice Of Publication E-Mailed
Dec 22, 2016
Approved For Pub - Principal Register
Dec 21, 2016
Assigned To Examiner
Sep 21, 2016
New Application Office Supplied Data Entered In Tram
Sep 20, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24